These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9629640)

  • 1. A mixed model for repeated dilution assays.
    Bloch J; Chavance M
    Biometrics; 1998 Jun; 54(2):482-92. PubMed ID: 9629640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viramune triple combo reduces viral load below limit of detection.
    AIDS Patient Care STDS; 1997 Dec; 11(6):456. PubMed ID: 11361870
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral drugs: new agents, new combinations line up against HIV.
    Phillips L
    Hosp Technol Ser; 1996 Jan; 15(1):1-3. PubMed ID: 10161344
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral load--how low is best?
    TreatmentUpdate; 1998 Dec; 10(10):2-3. PubMed ID: 11366016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bend in the road--implications of ACTG 175 and Delta trials.
    Hirsch MS; Yeni P
    Antivir Ther; 1996 Jan; 1(1):6-8. PubMed ID: 11322260
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
    Crowe S; Cooper DA; Chambers DE
    Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-retroviral treatment. Approach to previously treated patients].
    Antela A; Podzamczer D; Ruiz I; Parras F
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():24-30. PubMed ID: 9053023
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
    Foli A; Maserati R; Minoli L; Wainberg MA; Gallo RC; Lisziewicz J; Lori F
    AIDS; 1998 Jun; 12(9):1113-4. PubMed ID: 9662215
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
    AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic hepatitis C in patients coinfected with HIV: tolerability, drug interactions, therapeutic indications].
    Perronne C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B274-82. PubMed ID: 12180301
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple therapy in previously untreated patients reduces viral load below limit of detection.
    AIDS Patient Care STDS; 1996 Oct; 10(5):308-9. PubMed ID: 11361526
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy for adults and children.
    AIDS Inst Newsl; 1995 Jun; ():1-19. PubMed ID: 11367409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic strategies against HIV: status in 1994 and future prospectives].
    Internist (Berl); 1994 Jul; 35(7 Suppl):1-24. PubMed ID: 9131074
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside combinations for antiretroviral therapy: efficacy of stavudine in combination with either didanosine or lamivudine.
    Fisher M
    AIDS; 1998; 12 Suppl 3():S9-16. PubMed ID: 15168718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
    Haubrich R; Richman D
    JAMA; 1999 Jan; 281(2):130-1. PubMed ID: 9917108
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
    AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.